- In 2022, Eton Pharmaceuticals, a leading pharmaceutical business dedicated to commercializing and researching medicines for rare disorders, announced that they purchased betaine anhydrous for oral solution. Betaine anhydrous for an oral solution has a market of fewer than 2,000 patients in the U.S., with a projected annual market of $10 million
- In 2021, the Competition Commission of India approved Betaine B.V.'s acquisition of Hinduja Global Solutions' global healthcare BPO services business. Betaine acquired Hinduja Global Solutions' healthcare business process outsourcing (BPO) services and some assets, employees, contracts, and according to a statement from the fair trade authority
